Cargando…
Effect of Fibroblast Growth Factor 21 on the Development of Atheromatous Plaque and Lipid Metabolic Profiles in an Atherosclerosis-Prone Mouse Model
Fibroblast growth factor 21 (FGF21) is a hormonal regulator of lipid and glucose metabolism. We aimed to investigate the effect of an FGF21 analogue (LY2405319) on the development of atherosclerosis and its associated parameters. ApoE(−/−) mice were fed an atherogenic diet for 14 weeks and were rand...
Autores principales: | Maeng, Hyo Jin, Lee, Gha Young, Bae, Jae Hyun, Lim, Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555741/ https://www.ncbi.nlm.nih.gov/pubmed/32957703 http://dx.doi.org/10.3390/ijms21186836 |
Ejemplares similares
-
Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
por: Kim, Jin Hee, et al.
Publicado: (2021) -
Macrophages in Atheromatous Plaque Developmental Stages
por: von Ehr, Alexander, et al.
Publicado: (2022) -
Progression and Observational Frequency of Atheromatous Plaques in Autopsied Coronary Arteries
por: Lee, Wang-Soo, et al.
Publicado: (2009) -
The site-specific distribution of atheromatous plaques in the coronary arteries
por: Wasilewski, Jarosław, et al.
Publicado: (2023) -
Expression of NPP1 is regulated during atheromatous plaque calcification
por: Nitschke, Yvonne, et al.
Publicado: (2011)